文献速递关节外科

全膝关节置换术后阿片类药物使用:曲马多风险是否低于传统阿片类?

Opioid Use After Total Knee Arthroplasty: Does Tramadol Have Lower Risk Than Traditional Opioids?
PubMed 文献 · J Arthroplasty · 2020-01-28

基于Humana行政索赔数据库107,973例初次全膝关节置换患者,按术前3个月内是否开具阿片类或曲马多处方分层,追踪术后12个月处方索赔。术前使用曲马多者术后长期阿片类使用风险低于术前使用传统阿片类者,但均高于术前未使用两者者。

要点

  • 术前使用曲马多者术后12个月阿片类处方风险低于术前使用传统阿片类者。
  • 术前使用传统阿片类者术后长期阿片类使用风险最高。
  • 术前未使用阿片类或曲马多者术后长期阿片类使用风险最低。

核心结论

  • 术前使用曲马多的患者在全膝关节置换术后长期阿片类使用风险低于术前使用传统阿片类的患者。
  • 术前使用麻醉药品(阿片类或曲马多)的患者术后继续使用这些药物的比例高于术前未使用者。

研究设计与样本

  • 在Humana行政索赔数据库中识别接受初次全膝关节置换的患者。
  • 根据全膝关节置换术前3个月内是否开具阿片类、曲马多、两者或均未开具的处方进行分层。
  • 追踪术后12个月的处方索赔并计算各组的相对风险。

主要发现

  • 共识别107,973例接受全膝关节置换的患者。
  • 术前29,890例(27.7%)开具阿片类处方,8,049例(7.5%)开具曲马多处方,44,403例(41.1%)开具曲马多或阿片类处方,63,570例(58.9%)未开具两者处方。
  • 术后12个月,术前未使用麻醉药品者中6.0%开具阿片类处方,术前阿片类使用者中35.2%(RR 5.83 [5.63-6.03]),术前曲马多使用者中9.2%(RR 1.52 [1.40-1.63]),术前阿片类或曲马多使用者中29.5%(RR 4.88 [4.72-5.05])。
  • 术后12个月,术前未使用麻醉药品者中7.7%开具阿片类或曲马多处方,术前阿片类使用者中37.3%(RR 4.84 [4.70-4.99]),术前曲马多使用者中26.2%(RR 3.40 [3.26-3.57]),术前阿片类或曲马多使用者中35.7%(RR 4.64 [4.50-4.78])。

临床怎么用

  • 全膝关节置换术前应详细询问阿片类及曲马多使用史以评估术后长期阿片类使用风险。
  • 对术前使用曲马多者仍需警惕术后长期阿片类使用风险,尽管低于传统阿片类使用者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preoperative opioid use has been shown to increase postoperative opioid use following total knee arthroplasty (TKA). Tramadol is recommended for symptomatic treatment of osteoarthritis; however, it acts on opioid receptors and may confer similar adverse effects. The purpose of this study is to assess postoperative opioid use with preoperative opioid and tramadol use. METHODS: Patients undergoing primary TKA were identified in the Humana administrative claims database. Patients were stratified by whether they filled a prescription for an opioid, tramadol, either, or neither within 3 months of TKA. Prescription claims were tracked for 12 months postoperatively and relative risk for each group was calculated. RESULTS: In total, 107,973 patients undergoing TKA were identified. Preoperatively, 29,890 (27.7%) patients filled a prescription for opioids, 8049 (7.5%) for tramadol, 44,403 (41.1%) for tramadol or opioids, and 63,570 (58.9%) did not fill a prescription for either. At 12 months postoperatively, an opioid prescription was filled by 6.0% of preoperative narcotic-free patients, 35.2% opioid users (relative risk [RR] 5.83 [5.63-6.03]), 9.2% tramadol users (RR 1.52 [1.40-1.63]), and 29.5% opioid or tramadol users (RR 4.88 [4.72-5.05]). Opioid or tramadol prescriptions were filled by 7.7% of preoperative narcotic-free patients, 37.3% opioid users (RR 4.84 [4.70-4.99]), 26.2% tramadol users (RR 3.40 [3.26-3.57]), and 35.7% opioid or tramadol users (RR 4.64 [4.50-4.78]) at 12 months. CONCLUSION: Patients taking tramadol preoperatively were found to be at lower risk for prolonged postoperative opioid use following TKA. Patients taking either narcotics preoperatively continued use of these medications at a higher rate than those who were not.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. DeMik DE, Carender CN, Shamrock AG, et al. Opioid Use After Total Knee Arthroplasty: Does Tramadol Have Lower Risk Than Traditional Opioids? J Arthroplasty. 2020. PMID: 32057601. doi:10.1016/j.arth.2020.01.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。